吸烟与第二原发肺癌风险
该研究基于多民族队列7059例初发肺癌患者,评估第二原发肺癌(SPLC)危险因素,并在两个外部队列中验证。结果显示吸烟包年、每日吸烟量及符合USPSTF筛查标准均显著增加SPLC风险,确诊后戒烟与SPLC风险降低83%相关。
要点
- 吸烟包年和每日吸烟量是SPLC的显著危险因素。
- 初诊时符合2013 USPSTF筛查标准者SPLC风险约翻倍。
- 初发肺癌确诊后戒烟与SPLC风险降低83%相关。
核心结论
- 吸烟是第二原发肺癌的危险因素,戒烟可能降低SPLC风险。
研究设计与样本
- 分析多民族队列(MEC)1993–2017年7059例初发肺癌患者,采用病因特异性比例风险模型估计SPLC风险。
- 使用前列腺、肺、结直肠和卵巢癌筛查试验(N=3423例初发肺癌)和欧洲癌症与营养前瞻性调查(N=4731例初发肺癌)队列进行验证。
- 采用随机效应荟萃分析合并SPLC风险估计。
主要发现
- MEC队列中163例(2.3%)发生SPLC。
- 吸烟包年每增加10包年,SPLC风险HR=1.18(p<0.001)。
- 每日吸烟量每增加10支,SPLC风险HR=1.30(p<0.001)。
- 初诊时符合2013 USPSTF筛查标准者SPLC风险HR=1.92(p<0.001)。
- MEC中初发肺癌确诊后戒烟与SPLC风险降低83%相关(HR=0.17;p<0.001)。
关键数值与推荐
- 荟萃分析合并HR:每10包年1.16(pmeta<0.001)。
- 荟萃分析合并HR:每日每10支1.25(pmeta<0.001)。
- 荟萃分析合并HR:符合USPSTF标准1.99(pmeta<0.001)。
临床怎么用
- 对初发肺癌患者应评估吸烟包年与每日吸烟量以识别SPLC高危人群。
- 初诊时符合2013 USPSTF筛查标准者需加强SPLC监测。
- 确诊后应积极推荐戒烟以降低SPLC风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Lung cancer survivors are at high risk of developing a second primary lung cancer (SPLC). However, SPLC risk factors have not been established and the impact of tobacco smoking remains controversial. We examined the risk factors for SPLC across multiple epidemiologic cohorts and evaluated the impact of smoking cessation on reducing SPLC risk. METHODS: We analyzed data from 7059 participants in the Multiethnic Cohort (MEC) diagnosed with an initial primary lung cancer (IPLC) between 1993 and 2017. Cause-specific proportional hazards models estimated SPLC risk. We conducted validation studies using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (N = 3423 IPLC cases) and European Prospective Investigation into Cancer and Nutrition (N = 4731 IPLC cases) cohorts and pooled the SPLC risk estimates using random effects meta-analysis. RESULTS: Overall, 163 MEC cases (2.3%) developed SPLC. Smoking pack-years (hazard ratio [HR] = 1.18 per 10 pack-years, p < 0.001) and smoking intensity (HR = 1.30 per 10 cigarettes per day, p < 0.001) were significantly associated with increased SPLC risk. Individuals who met the 2013 U.S. Preventive Services Task Force's screening criteria at IPLC diagnosis also had an increased SPLC risk (HR = 1.92; p < 0.001). Validation studies with the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and European Prospective Investigation into Cancer and Nutrition revealed consistent results. Meta-analysis yielded pooled HRs of 1.16 per 10 pack-years (pmeta < 0.001), 1.25 per 10 cigarettes per day (pmeta < 0.001), and 1.99 (pmeta < 0.001) for meeting the U.S. Preventive Services Task Force's criteria. In MEC, smoking cessation after IPLC diagnosis was associated with an 83% reduction in SPLC risk (HR = 0.17; p < 0.001). CONCLUSIONS: Tobacco smoking is a risk factor for SPLC. Smoking cessation may reduce the risk of SPLC. Additional strategies for SPLC surveillance and screening are warranted.
引用
- Aredo JV, Luo SJ, Gardner RM, et al. Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 2021. PMID: 33722709. doi:10.1016/j.jtho.2021.02.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。